627 related articles for article (PubMed ID: 22030384)
21. Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence.
Garefalakis M; Hickey M
Clin Interv Aging; 2008; 3(1):1-8. PubMed ID: 18488873
[TBL] [Abstract][Full Text] [Related]
22. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
[TBL] [Abstract][Full Text] [Related]
23. Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial.
Fallowfield L; Cella D; Cuzick J; Francis S; Locker G; Howell A
J Clin Oncol; 2004 Nov; 22(21):4261-71. PubMed ID: 15514369
[TBL] [Abstract][Full Text] [Related]
24. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
25. Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a Tamoxifen Exemestane Adjuvant Multicenter trial substudy.
Jones SE; Cantrell J; Vukelja S; Pippen J; O'Shaughnessy J; Blum JL; Brooks R; Hartung NL; Negron AG; Richards DA; Rivera R; Holmes FA; Chittoor S; Whittaker TL; Bordelon JH; Ketchel SJ; Davis JC; Ilegbodu D; Kochis J; Asmar L
J Clin Oncol; 2007 Oct; 25(30):4765-71. PubMed ID: 17947724
[TBL] [Abstract][Full Text] [Related]
26. Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms.
Bouchard P; Panay N; de Villiers TJ; Vincendon P; Bao W; Cheng RJ; Constantine G
Climacteric; 2012 Feb; 15(1):12-20. PubMed ID: 22066790
[TBL] [Abstract][Full Text] [Related]
27. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
[TBL] [Abstract][Full Text] [Related]
28. The need for tissue selective menopausal agents.
Eden J
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():22-7. PubMed ID: 16112952
[TBL] [Abstract][Full Text] [Related]
29. Effect of tibolone on sexual function in late postmenopausal women.
Kamenov ZA; Todorova MK; Christov VG
Folia Med (Plovdiv); 2007; 49(1-2):41-8. PubMed ID: 18018469
[TBL] [Abstract][Full Text] [Related]
30. A survey among breast cancer survivors: treatment of the climacteric after breast cancer.
Antoine C; Vandromme J; Fastrez M; Carly B; Liebens F; Rozenberg S
Climacteric; 2008 Aug; 11(4):322-8. PubMed ID: 18645698
[TBL] [Abstract][Full Text] [Related]
31. Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy.
Wu MH; Pan HA; Wang ST; Hsu CC; Chang FM; Huang KE
Climacteric; 2001 Dec; 4(4):314-9. PubMed ID: 11770188
[TBL] [Abstract][Full Text] [Related]
32. Effects of tibolone on the breast of postmenopausal women.
Wang PH; Cheng MH; Chao HT; Chao KC
Taiwan J Obstet Gynecol; 2007 Jun; 46(2):121-6. PubMed ID: 17638619
[TBL] [Abstract][Full Text] [Related]
33. Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality.
Genazzani AR; Stomati M; Valentino V; Pluchino N; Pot E; Casarosa E; Merlini S; Giannini A; Luisi M
Climacteric; 2011 Dec; 14(6):661-8. PubMed ID: 21942655
[TBL] [Abstract][Full Text] [Related]
34. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
Buckler H; Al-Azzawi F;
BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of tibolone and menopausal transition: a randomized, double-blind placebo-controlled trial.
Morais-Socorro M; Cavalcanti MA; Martins R; Neto Francisco P; Rezende A; Azevedo G; Almeida M
Gynecol Endocrinol; 2012 Jun; 28(6):483-7. PubMed ID: 22132809
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
Zhou YZ; Sun LZ; Lin JF; Yang X; Zhang LJ; Qiao J; Wang ZH; Xu YX; Xiong ZA; Lin SQ
Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370
[TBL] [Abstract][Full Text] [Related]
37. What have we really learned from 'LIBERATE' trial?
Dimitrakakis C; Tsigginou A; Keramopoulos D; Antsaklis A
Maturitas; 2010 May; 66(1):99-100. PubMed ID: 20236777
[TBL] [Abstract][Full Text] [Related]
38. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women.
Laan E; van Lunsen RH; Everaerd W
Climacteric; 2001 Mar; 4(1):28-41. PubMed ID: 11379375
[TBL] [Abstract][Full Text] [Related]
39. Does a homeopathic medicine reduce hot flushes induced by adjuvant endocrine therapy in localized breast cancer patients? A multicenter randomized placebo-controlled phase III trial.
Heudel PE; Van Praagh-Doreau I; Duvert B; Cauvin I; Hardy-Bessard AC; Jacquin JP; Stefani L; Vincent L; Dramais D; Guastalla JP; Blanc E; Belleville A; Lavergne E; Pérol D
Support Care Cancer; 2019 May; 27(5):1879-1889. PubMed ID: 30194492
[TBL] [Abstract][Full Text] [Related]
40. Effect of tibolone on breast cancer cell proliferation in postmenopausal ER+ patients: results from STEM trial.
Kubista E; Planellas Gomez JV; Dowsett M; Foidart JM; Pohlodek K; Serreyn R; Nechushkin M; Manikhas AG; Semiglazov VF; Hageluken CC; Singer CF
Clin Cancer Res; 2007 Jul; 13(14):4185-90. PubMed ID: 17634547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
